Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lilly and Incyte Announce Patients Treated with Baricitinib Demonstrated Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis Compared with Methotrexate 2015-11-09 09:49
Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal Phase 3 Study in Patients with Rheumatoid Arthritis 2015-09-29 18:45
Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance in Certain Countries 2014-10-29 20:00
Lilly and Alzheimer's Disease International Partner to Address Barriers that Impact the Accurate and Timely Diagnosis of Alzheimer's Disease 2014-06-12 15:00
Lilly Releases Report on Corporate Responsibility Efforts 2013-12-06 06:12
Amyvid (Florbetapir (18F)) Solution for Injection Approved in European Union for Use in Patients with Cognitive Impairment Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Impairment 2013-01-16 04:06
Lilly Releases Update on Corporate Responsibility Efforts 2012-12-03 20:00
European Commission Approves Cialis for the Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia 2012-10-30 21:39
ALIMTA(R) Label Update Approved by European Commission to Reflect Significant Overall Survival Benefits for Specific Lung Cancer Patients 2012-10-30 21:22
Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient(R) (Prasugrel) in Acute Coronary Syndrome UA/NSTEMI Patients to be Managed Medically without an Artery-Opening Procedure 2012-08-27 08:07
1 2